<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Physiology Anatomy and Genetics</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DDD240F0-BF92-43B0-A7BA-57217BB59E46"><gtr:id>DDD240F0-BF92-43B0-A7BA-57217BB59E46</gtr:id><gtr:firstName>Trevor</gtr:firstName><gtr:surname>Sharp</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DE32C476-09A8-4BCA-A101-9312BFB03827"><gtr:id>DE32C476-09A8-4BCA-A101-9312BFB03827</gtr:id><gtr:firstName>Daniel</gtr:firstName><gtr:otherNames>Clive</gtr:otherNames><gtr:surname>Anthony</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3E5976A0-A73A-48DA-8DFD-A02C982BDEFA"><gtr:id>3E5976A0-A73A-48DA-8DFD-A02C982BDEFA</gtr:id><gtr:firstName>Nicola</gtr:firstName><gtr:otherNames>Ruth</gtr:otherNames><gtr:surname>Sibson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0401355"><gtr:id>E8D46B21-47B0-4C3B-9E37-609A99179D64</gtr:id><gtr:title>Pathfinder Investigation of the Effects of Inflammation on Brain Serotonin Function: Relevance to Depression</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401355</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>173329</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Grant from Pfizer Ltd</gtr:description><gtr:id>D25AE0CB-42BA-49B4-855A-71B3D4CA5FCB</gtr:id><gtr:impact>The postdoc employed under this grant from Pfizer wrote the review of functional imaging in the 5HT system (PMID: 18789342) and which included some details of the work we undertook under this Pathfinder grant.</gtr:impact><gtr:outcomeId>CD07210A736-1</gtr:outcomeId><gtr:piContribution>This was a two year research grant with funding to extend our 5HT fMRI research into a different, but related, area based on our success in the 5-HT system under the Pathfinder Grant.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MSc and DTC Lectures</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BE97F8E7-853D-4E87-B647-3270ABA8EDA3</gtr:id><gtr:impact>Regular lectures on brain imaging in cancer and neurosciences to Doctoral Training Course and M.Sc. students, which sparked questions and discussion as well as interest in entering research within this field of research. Outcome is often one or more students joining the group for either M.Sc. or D.Phil. projects.

Development of collaborations and numerous examples of interest in applying our VCAM-targeted technology in different patients groups from paediatrics to head injury.</gtr:impact><gtr:outcomeId>T9JFKsp4YRH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>76339</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC PhD Studentship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>598065F1-6FB7-40AB-9D4C-6A1B55844485</gtr:id><gtr:outcomeId>028BECB1C5B0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>John Fell Fund</gtr:department><gtr:description>Oxford University John Fell Fund</gtr:description><gtr:end>2011-05-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>B443B8E6-51DF-4E71-A82A-15284A3B96D7</gtr:id><gtr:outcomeId>iRRn5YXEmJ20</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>28000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Strategic Skills Awards</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>653DBA70-0458-4BD5-AA6E-CCA58AA5DD8E</gtr:id><gtr:outcomeId>ZmYpgKB4ciV0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>524445</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Fellowship</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>8A9064E1-75A5-4F6F-9492-8F6DE250036D</gtr:id><gtr:outcomeId>0180FAAF8B70</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>256289</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>093223</gtr:fundingRef><gtr:id>378695C2-EFAC-4143-8188-05E27ED93D99</gtr:id><gtr:outcomeId>WhBhE9n84mG0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>124AE197-AA25-4528-8D45-D1A98977833C</gtr:id><gtr:title>Systemic inflammation alters central 5-HT function as determined by pharmacological MRI.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/051ad9a9d71f82e07d02db87a1661b48"><gtr:id>051ad9a9d71f82e07d02db87a1661b48</gtr:id><gtr:otherNames>Couch Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pm_12973_23_23473937</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7202813C-20F4-4781-8095-5B78BAAA0211</gtr:id><gtr:title>Anti-inflammatory Microglia/Macrophages As a Potential Therapeutic Target in Brain Metastasis.</gtr:title><gtr:parentPublicationTitle>Frontiers in oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60632903f42286c00af57324cc9419ea"><gtr:id>60632903f42286c00af57324cc9419ea</gtr:id><gtr:otherNames>Andreou KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2234-943X</gtr:issn><gtr:outcomeId>5a8d548324bf93.68832030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4E20AC2-F00F-4748-81D2-85786372C1EE</gtr:id><gtr:title>Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d62528515323b140c0b7f1efac5703d3"><gtr:id>d62528515323b140c0b7f1efac5703d3</gtr:id><gtr:otherNames>Jurynczyk M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>5a8d5457625cf3.19694533</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4705643C-48F4-45BE-9B80-B395C8B9E3F4</gtr:id><gtr:title>A Critical Role for Astrocytes in Hypercapnic Vasodilation in Brain.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ac22d45021541ad668bc8bc7a1ae847"><gtr:id>4ac22d45021541ad668bc8bc7a1ae847</gtr:id><gtr:otherNames>Howarth C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>5a8d54c485b6b0.68511750</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4AD9043-BEB6-446C-AE05-B3584F8E1426</gtr:id><gtr:title>Pharmacological MRI in animal models: a useful tool for 5-HT research?</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5292dfe7dacdc3f4f68dd2c4085a1b06"><gtr:id>5292dfe7dacdc3f4f68dd2c4085a1b06</gtr:id><gtr:otherNames>Martin C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>4DE43A84361</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>791382AE-D25B-44D1-B748-E7F474B7FC70</gtr:id><gtr:title>Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases.</gtr:title><gtr:parentPublicationTitle>Theranostics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57211aa66774a9287dec3e1a588d4212"><gtr:id>57211aa66774a9287dec3e1a588d4212</gtr:id><gtr:otherNames>Falzone N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1838-7640</gtr:issn><gtr:outcomeId>5a8d541eabf4f8.38773046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4977DFB0-A32F-4B30-84BD-DA573746A9A9</gtr:id><gtr:title>Corrigendum to &amp;quot;Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits&amp;quot; [Clin Oncol 27 (7) (2015) 420-426].</gtr:title><gtr:parentPublicationTitle>Clinical oncology (Royal College of Radiologists (Great Britain))</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0138c64d17104e9f5521c9f5f058fc6"><gtr:id>e0138c64d17104e9f5521c9f5f058fc6</gtr:id><gtr:otherNames>Ray KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0936-6555</gtr:issn><gtr:outcomeId>5a8d55a550c401.27117578</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5842EA9-EDD0-4B5F-8FF9-047989288AB5</gtr:id><gtr:title>Evidence that increased 5-HT release evokes region-specific effects on blood-oxygenation level-dependent functional magnetic resonance imaging responses in the rat brain.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78c7b593428f67139ccf97c3f4d42dce"><gtr:id>78c7b593428f67139ccf97c3f4d42dce</gtr:id><gtr:otherNames>Preece MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>1B50D89E1E8</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0401355</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>